Intellia Therapeutics, Inc. NTLA
9.78 USD -0.08 (-0.81%)
Regular-session close
9.88 +0.10 +1.02%
After hours · Nov 17, 7:20 PM ET
9.69 Day range 10.24
8.04 52-week range 17.84
- YTD
- +8.79%
- 1 year
- +15.33%
Benzinga news
benzinga.com Intellia Therapeutics Q3 EPS $(0.91) Misses $(0.80) Estimate, Sales $7.163M Miss $10.461M Estimate Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.80) by 15.19 percent. This is a 1.09 percent increase over losses…
benzinga.com Intellia Therapeutics Completed Participant Enrollment In Its MAGNITUDE-2 Study Of ATTRv-PN Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced the…
